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Tramadol combines an m opiate and nonopiate analgesic mechanism and might be
a useful opioid in horses. This study evaluated the effect of IV tramadol on spontaneous
locomotor activity (SLA), head height, and hoof withdrawal reﬂex (HWR) after thermal or
electrical nociceptive stimuli in horses. Doses of 2 and 3 mg/kg tramadol did not affect
HWR after electrical and thermal nociception, respectively. Head height and SLA were
not modiﬁed by 2, 3, or 5 mg/kg tramadol. All horses treated with 5 mg/kg tramadol
developed trembling in pectoral triceps, and gluteal muscles and adopted a base-wide
stance. In conclusion, 2 and 3 mg/kg tramadol IV neither induced sedation nor pro-
longed HWR after thermal or electrical stimuli in conscious horses. The dose of 5 mg/kg
tramadol IV produced excitement, and it is apparently unsuitable for clinical use.
 2013 Elsevier Inc. All rights reserved.1. Introduction
The use of opioid analgesic agents in horses is still
limited because of signiﬁcant adverse effects. There are
reports of increased spontaneous locomotor activity when
opioids are administered IV [1-3]. Tramadol might be
a useful drug in these species, as it combines a m opiate and
nonopiate analgesic mechanism [4]. The compound is
composed by a racemic mixture. The enantiomer (þ)-
tramadol inhibits the reuptake of serotonin, whereas the
enantiomer ()-tramadol inhibits the reuptake of norepi-
nephrine; both components inhibit pain transmission at
the spinal cord [5].eira, DVM, Depart-
hool of Veterinary
aulista, Postal Code
iveira).
ll rights reserved.Adverse effects are less pronounced when tramadol is
compared to pure opioid agonists, when appropriate route
and method of administration are used [6]; however,
analgesia is apparently limited in horses [7], possibly
because horses are low metabolizers of tramadol [6].
Following administration of 2 mg/kg tramadol IV, clearance
was 26  3 [6] and 20  6 mL/kg/min [7], apparent volume
of distribution at steady state was 2.17  0.52 L/kg [6]
and 2.48  0.74 L/kg [7], mean residence time was 83 
10 min; and terminal half-life was 82  10 min [6] and
126  54 min [7].
Administration of an IV bolus of 2.0 mg/kg tramadol
(Tramal; Pﬁzer, São Paulo, Brazil) did not prolong the time
of response to a thermal stimulus in horses [7], pointing to
the need for further studies to establish its antinociceptive
effect using different doses and types of stimuli. Accord-
ingly, in the present study, a higher dose of tramadol IV was
used to test thermal stimuli, to investigate whether anti-
nociception might be related to a dose-dependent effect.
Another type of stimuli (electrical) was also included to
A. Santi Milaré et al. / Journal of Equine Veterinary Science 33 (2013) 823-826824investigate if antinociception might be mediated by
a different pain pathway.
The aim of this investigationwas to evaluate the effect of
tramadol on hoof withdrawal reﬂex (HWR) after thermal or
electrical nociceptive stimuli and on SLA in horses.2. Materials and Methods
The study was approved by the Institutional Animal
Research Committee under protocols 117/2008-CEEA and
016917-07-CEBEA. Horses were selected from the Univer-
sity breeding stock and considered healthy after clinical
examination and blood cell count. Food but not water was
withheld for 12 hours before the study.
Two sets of experiments were carried out using
a different group of animals, six for thermal and ﬁve for
electrical stimuli, in two different occasions and research
environments. Electrical or thermal stimuli were applied to
the shaved cranial surface of the proximal phalanx of the
thoracic limb proximal to the coronary band of the horses
[3]. Nociceptive stimulus was maintained until limb with-
drawal and was repeated two and three times for the
thermal and electrical stimuli, respectively. Horses were
monitored for signs of colic and other adverse effects
(excitement, trembling, and restlessness). Response to
stimuli was investigated by the same observer in each case.62.1. Electrical Stimuli
Five adult horses (one gelding and four mares) weighing
410  25 kg (range, 385-435 kg) and 10.2  2.3 years old
(range 8-14 years old) were used. Horses were restrained in
stocks. Electrical stimuli were performed via two surface
electrodes for electrocardiogram recordings, ﬁrmly ﬁxed
with tape over the area and attached to an electrical
stimulator (Grass S-48; Astro-Med Inc., West Warwick, RI),
adjusted to deliver alternate current square waves (50 Hz
and 10ms). Voltagewas initially set at 1 V, with progressive
increments of 1 V every 5 seconds until HWRwas observed.
At that moment, the stimulus was stopped and the corre-
sponding voltage intensity (V) was recorded. A maximal
stimulus of 5 V was achieved in all cases. HWR was deter-
mined before and every 10 minutes for 60 minutes after 2
mg/kg tramadol IV.0
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Fig. 1. Mean (SD) voltage for hoof withdrawal reﬂex in response to elec-
trical stimulation after IV administration of tramadol (2 mg/kg) in horses
(n ¼ 6).2.2. Thermal Stimuli
Six adult horses (three geldings and three mares)
weighing 400  15 kg (range, 385-415 kg) and 7.2  1.9
years old (range, 5-10 years old) were used. Horses were
restrained by a halter. Shaved skin was painted with black
water-based ink for uniform light reﬂection and heat
absorption. A projection lamp operated by the same
investigator was used for heat exposure. HWR was ob-
tained by a precision timer (accuracy, 0.001 seconds) before
and at 10, 20, 30 45, 60, and 90 minutes after 3 mg/kg
tramadol IV [4]. The nociceptive stimulus was applied for
a maximum of 10 seconds to avoid tissue injuries. A lateral
nonfocused lamp was frequently used to avoid condi-
tioning response to light perception.2.3. Spontaneous Locomotor Activity
Spontaneous locomotor activity (SLA) was investigated
in another occasion in a behavioral stall by use of infrared
photoelectric sensors connected to a computer to detected
movement of each horse. The same animals used for
thermal stimulation test were used. SLA was recorded and
behavior observed before and at 10, 15, 30, 60, 90, 120, 150,
and 180 minutes after administration of 2, 3, or 5 mg/kg
tramadol IV, using a crossover randomized design.
Behavior was observed outside the stall by a small window.
Signs of excitement (restlessness, head nodding, digging,
shifting of limbs, vocalizing, trotting, and galloping) were
recorded but not quantiﬁed. Head height (chin-to-ﬂoor
distance) was measured for sedation evaluation by a ruler
on the stall wall.2.4. Statistical Analysis
Statistical analysis was performed using Graph Pad
Prism 5 software. For variables with normal distribution,
according to a Kolgomorov-Smirnov test, ANOVA followed
by a Dunnett test for comparisonswithin a treatment group
or by a Tukey test for comparisons among/between treat-
ment groups was performed. Differences were considered
signiﬁcant when P value was <.05.3. Results
IV administration of 2 or 3 mg/kg tramadol did not
prolong HWR to thermal and electrical stimuli, respec-
tively. Baseline HWR for electrical and thermal stimuli were
2.9  0.4 volts (maximal value at 50 minutes: 3.6  1.2
volts) (Fig. 1) and 5.2 2.3 seconds, respectively (Fig. 2). All
horses receiving 5 mg/kg tramadol developed trembling in
pectoral, triceps, and gluteal muscles and adopted a base-
wide stance during the SLA evaluation; therefore, it was
decided not to use a dose of 5 mg/kg to evaluate thermal
antinociceptive effect, and 3 mg/kg was chosen for this
purpose.
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Fig. 2. Mean (SD) time (seconds) for hoof withdrawal reﬂex in response to
thermal stimulation after IV administration of tramadol (3 mg/kg) in horses
(n ¼ 6).
Table 2
Mean (SD) head height (cm) after IV administration of 2, 3, and 5 mg/kg
tramadol in horses (n ¼ 6)
Moments (minutes) Mean  SD Activity per Tramadol Dose
2 mg/kg 3 mg/kg 5 mg/kg
5 1.11  0.02 1.06  0.05 1.13  0.04
10 1.13  0.05 0.98  0.08 1.14  0.04
20 1.1  0.06 1.04  0.06 1.10  0.03
30 1.1  0.04 0.95  0.10 1.08  0.04
60 1.09  0.06 0.93  0.03 1.12  0.08
90 1.07  0.05 0.99  0.06 1.01  0.12*
120 1.02  0.10* 1.04  0.07 1.13  0.03
150 1.07  0.06 1.06  0.09 1.08  0.05
180 1.09  0.07 1.12  0.08* 1.13  0.04
* Signiﬁcantly different than baseline (P < .05).
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between 2, 3, or 5 mg/kg tramadol IV (Table 1) when the
head height was concerned. Head height decreased at 120
and 90 minutes compared to basal values after 2 and 5 mg/
kg tramadol and increased at 180 minutes after 3 mg/kg
tramadol (Table 2).
4. Discussion
The use of different kinds of nociceptive stimuli allows
the investigation of different categories of receptors and
nociceptive pathways [8]. Both the heat lamp and the
electrical stimuli are commonly used methods to investi-
gate antinociception produced by analgesics in horses
[1,3,7,9].
Considering that there was no thermal antinociception
after 2 mg/kg tramadol IV as previously described [7],
a larger dose of tramadol was used in this study (3 mg/kg)
to investigate a possible dose-related effect of tramadol on
thermal antinociception. Another hypothesis tested here
was the likely difference in antinociception produced by
tramadol, according to the quality of nociceptive stimuli
(i.e., electrical). In horses, slow heating rates are used for
thermal stimulation [3,7], which possibly activate C ﬁbers
[8]. Progressively increased electrical stimuli used here
initially activates Ab, then Ad, and ﬁnally C ﬁbers [10].
Accordingly, we hypothesized that a possible anti-
nociception against electrical stimulus might be producedTable 1
Mean (SD) spontaneous locomotor activity (number of interruptions/
minute) after IV administration of 2, 3, and 5 mg/kg tramadol in horses
(n ¼ 6)
Moments (min) Mean  SD Activity per Tramadol Dose
2 mg/kg 3 mg/kg 5 mg/kg
0 7.40  2.56 14.0  4.47 5.50  2.71
10 11.83  4.07 12.2  6.44 17.93  7.3
15 8.03  3.86 9.73  4.74 19.53  6.17
30 7.36  2.54 8.36  3.83 14.23  7.51
60 5.90  2.85 8.66  3.89 11.66  6.59
90 5.50  3.10 21.96  5.23 11.50  5.46
120 7.13  3.66 25.31  5.87 8.66  4.63
150 9.33  4.36 20.28  5.58 21.96  10.86
180 10.33  4.20 13.76  5.47 12.26  6.08by tramadol; however, this was not observed as HWR did
not increase after electrical stimulation.
In humans, the major tramadol metabolite presented in
the plasma is O-desmethyltramadol (M1), which is the
main metabolite with analgesic activity [5]. Horses are
considered low tramadol metabolizers, showing low serum
concentrations of the metabolite M1 [6], suggesting that
tramadol may be less effective in horses than in other
species. Although the epidural injection of tramadol in
horses increased the avoidance threshold to electrical
nociceptive stimulus in perineal, sacral, and lumbar areas
[1] and induced only light analgesia for approximately 10
minutes against electrical stimulation [11], the results
observed here using both thermal and electrical stimuli
showed that IV tramadol did not produce antinociceptive
effects for both stimuli.
Signs of central nervous system (CNS) excitement was
not evident when tramadol was injected epidurally [1], but
when it was administered IV, CNS excitation such as excited
behavior, increased sensitivity to noise and stimulation,
trembling, head nodding, muscle tremor, yawning, and
chewing were observed [7,11]. This study showed that IV
administration of 5 mg/kg tramadol produced muscle
trembling and reduced head height but did not modify SLA
as previously reported [6,7,11]. Increased SLA is a common
ﬁnding when opioids are used in horses not suffering pain
[3,12], and the fact that tramadol does not increase SLA
might be an advantage; however the antinociceptive effect
of this dose must be investigated under clinical conditions.
The following limitations of the study should be
considered. Although a small number of animals was used,
data were very consistent in all animals, as no anti-
nociception was observed in any horse when we used both
thermal and electrical stimuli. A negative control group
(saline) was not included in the study, as horses were
accustomed to being handled and were well adapted to the
environment. The different dose regimens used to test
thermal and electrical stimuli were initially based on the
hypothesis that a higher dose of tramadol (3 mg/kg) might
produce thermal antinociception, which was not observed
using a lower dose as previously reported [7]. Otherwise,
the dose of 2 mg/kg tramadol was used for the electrical
testing, because no serum tramadol and metabolite
concentrations were measured in this study, and single-
bolus pharmacokinetic data were available only for this
dose [6].
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opioids in horses under experimental conditions might be
related to differences in density and afﬁnity of opioid
receptors compared to those in other species [13].
However, the absence of data regarding the functional role
of these receptors adapted to the experimental and clinical
conditions restrict further explanations of these ﬁndings.
The model used in this study also might not have been
sufﬁciently sensitive to detect antinociception as animals
were not suffering clinical pain. Other methods using
inﬂammatory models, like capsaicin administration and
skin incision, might have been used; however, these kinds
of models are currently used to test anti-inﬂammatory
instead of opioid effects [14].
In conclusion, 2, 3, and 5 mg/kg IV tramadol neither
induced sedation nor increased spontaneous locomotor
activity as well as the lower doses of 2 and 3 mg/kg tra-
madol IV did not produce thermal or electrical anti-
nociception in conscious horses, respectively. The dose of 5
mg/kg IV tramadol produced excitement, and it is appar-
ently unsuitable for clinical use.
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